Bladder Cancer India’s Post

Diagnostic trajectories in #sarcoma and #rarecancerpatients-in-general are often complex with delays at different levels due to the unfamiliarity of people, (the later)patients, and doctors with the disease and the heterogeneity in histologies and clinical presentations. This may lead to late diagnoses and frustration at all levels and reduced HRQoL of patients. Olga Husson presented at #ESMOSarcomaRareCancers meeting in Lugano results of a study in the Netherlands on diagnostic trajectories of rare cancer patients and Emily Holthuis, PhD student of our team, presents a poster today with interesting results of symptoms reported by patients to their GP prior to their #sarcoma diagnosis. The discussant yesterday highlighted results of our QUEST study in which we compare diagnostic trajectory data between the UK and The Netherlands in #Sarcoma (Vicky Soomers). More results will follow the coming time. Grateful to the hard work of our research team #AYASARCOMA The Netherlands Cancer Institute Olga Husson. Hopefully this work will give us hints for the future in solving part of this difficult to crack multifactorial delay-in-diagnosis issue.

"Navigating Hope: Dr. Suhail Qureshi Explores Advances in Stage 4 Cancer Treatment and Long-Term Outcomes" While a complete cure for stage 4 cancer is challenging, advances in cancer research and treatment continue to improve outcomes, and some individuals do achieve long-term remission or live with the disease as a chronic condition. Here’s Dr. Suhail Qureshi, Senior Consultant and Unit Head, Medical Oncology, Fortis Hospital, Shalimar Bagh, New Delhi, shedding light on the circumstances under which stage 4 cancer can be effectively treated. https://lnkd.in/gxgB3bKi Deepak Narang Rishi Mehra Rajeev Nayyar Rajeev Kapur Dr.Archana Bajaj girja sharma Shubham Jain Mahipal Singh Bhanot Arvind Pahwa Nikita Singh Balram Sharma Fortis Healthcare #healthawareness #fortishospital #fortishealthcare #CareForGood #Stage4Cancer #CancerResearch #MedicalOncology #HopeInCancer #TreatmentAdvances #CancerSurvivorship #ChronicCondition #CancerCare

Have questions about oral cancer? Get the answers you need in our new Q&A video with a leading expert at Nanavati Hospital! #OralCancerAwareness #NanavatiHospital

𝐀 𝐏𝐨𝐭𝐞𝐧𝐭𝐢𝐚𝐥 𝐆𝐚𝐦𝐞-𝐂𝐡𝐚𝐧𝐠𝐞𝐫 𝐟𝐨𝐫 𝐂𝐨𝐥𝐨𝐧 𝐂𝐚𝐧𝐜𝐞𝐫 𝐒𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 🔬 Colonoscopy - the gold standard, yet invasive. Stool tests - effective but...the "ick factor". What if there was an easier option? A new study reveals a promising blood test that detected 83% of colon cancers. With a false positive rate of only 10%. While not as accurate as colonoscopy... It offers a compelling alternative screening approach. The Impact? Potentially Transformative. Over 50% of eligible adults skip colon cancer screening. A simple blood draw could motivate the unscreened masses. Early detection is key for successful treatment. This blood test may save countless lives. In the fight against colon cancer, this innovative screening method deserves serious consideration from medical professionals and the public alike. P.S. 𝐖𝐨𝐮𝐥𝐝 𝐲𝐨𝐮 𝐨𝐩𝐭 𝐟𝐨𝐫 𝐭𝐡𝐢𝐬 𝐛𝐥𝐨𝐨𝐝 𝐭𝐞𝐬𝐭 𝐨𝐯𝐞𝐫 𝐜𝐮𝐫𝐫𝐞𝐧𝐭 𝐬𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐦𝐞𝐭𝐡𝐨𝐝𝐬? #oncolyst #oncology #cancer #cancerresearch #oncologist Image source: Dr. Nikhil Agrawal

Why cancer treatment in Turkey? The International Agency for Research on Cancer uses survival rates to measure the effectiveness of treatment in different countries. This is the percentage of patients who lived at least five years after their cancer diagnosis. In Turkey, the survival rate of women with breast cancer is 78.6%. In patients with prostate cancer - 80.6%. The survival rate for stomach cancer is more than 17%, a figure comparable to countries such as Denmark - 17.9% and the UK - 18.5%. The best doctors and hospitals are affordable and certified to the highest standards. Our main goal is your health, which you can combine with your holiday. We help patients from all over the world to get quality medical care in Turkiye with the highest standards and affordable prices. #healthyturkiye #medicaltourismturkey #medicaltourism #healthtourismturkey #cancertreatment #oncology #oncologists

Angelina Jolie's case is one of the most recognized in genomic medicine. She had a strong family history of cancer. When she did BRCA testing, she found mutations that increased her risk of cancer. Breast cancer is topmost cancer affecting in Indian women. October is breast cancer awareness month. In our article in The Hindu, Dr. Anup Rawool and Vid Karmarkar, PhD, we discuss importance of and inequities in BRCA testing. What are your views about BRCA testing? Link to the article is in the comments below. #cancer #breastcancerawareness #breastcancer #publichealth #canseva #sahaj #pinkoctober #healthcare #genetictesting #genomics

Breast Cancer Awareness Month: The Power of BRCA Testing October is Breast Cancer Awareness Month, a crucial time to highlight the importance of early detection and prevention, especially through BRCA testing. As featured in a recent article by Dr. Anup Rawool and Vid Karmarkar, PhD in The Hindu, BRCA testing can be a game-changer in the fight against hereditary cancers. Angelina Jolie’s well-known story is a powerful example of the impact of genetic testing. With a strong family history of cancer, she opted for BRCA testing, which revealed mutations that significantly increased her risk. This knowledge empowered her to take proactive measures and reduce her risk through preventive surgery. In India, where breast cancer is the most prevalent cancer among women, such testing can be life-saving. However, equitable access to BRCA testing remains a challenge, with many high-risk individuals unable to afford the cost or unaware of the benefits. Addressing this requires a dual approach: Raising Awareness: Educating the public about the benefits of genetic testing and how it can guide personalized preventive care. Making Testing More Accessible: Reducing the cost of BRCA testing and ensuring availability, especially in underserved populations. As we observe #PinkOctober, let’s focus on making genetic testing accessible for all. Early detection can save lives, but only if the right tools are within reach for everyone, not just a few. Together, we can advocate for a future where every woman has the chance to understand her risks and take charge of her health. What are your thoughts on the role of genetic testing in cancer prevention? #BreastCancerAwareness #BRCA #GeneticTesting #PublicHealth #CancerPrevention #PinkOctober #HealthcareEquity #WomensHealth

🌟Insights into Metabolomics and Application in Colorectal Cancer Research🌟 Assistant Professor Jennifer Ose from the University of Utah Health, Department of Population Health, offered a compelling talk on "Metabolomics and its Application in Colorectal Cancer Research." This presentation was one of the highlights of the virtual event "Population Health and Cancer: The Power of Multi-Omics in Cohort Studies." Dr. Ose's discussion provided a deep insight into how metabolomics is revolutionizing our understanding of colorectal cancer. The talk provided not only profound comprehension but also showcased the potential for metabolomics to pave the way for important advancements in cancer research, diagnosis, and treatment strategies. For those interested in the intersection of population health and cancer research and missed the virtual event or want to rewatch, catch the full recording here: https://lnkd.in/dH5ks-et #Cancer #Research #Metabolomics #PopulationHealth

🎉 I am excited to announce that our recent study, "Predictive Factors Associated with Health-Related Quality of Life in Patients with Colorectal Cancer in Iran: A Cross-Sectional Study," has been published in BMJ Open! (IF=2.4, Q1) This research highlights key factors influencing the health-related quality of life (HRQoL) in colorectal cancer patients, with significant findings that can help improve patient care in this critical area. We explored how factors such as comorbidities, treatment type, and socio-demographic characteristics predict HRQoL, with implications for tailored interventions that can enhance patient outcomes. A big thank you to my co-authors, Mohamad Hasan Sahebihagh and Neda Gilani, as well as the entire team involved in this study. It was a privilege to work on such impactful research, and we hope it contributes meaningfully to the field of cancer care. You can read the full article here: https://lnkd.in/enaVUvSE #ColorectalCancer #HRQoL #CancerResearch #BMJOpen #HealthOutcomes #Research

April is #TesticularCancer Awareness Month 📣 And we are passionate about bringing you the latest news & updates 🎥 🗞️ Ciara Conduit, FRACP, MBBS, PGCert MEd, Peter MacCallum Cancer Centre, discusses unmet needs in #testicularcancer, including #mentalhealth issues such as #stress and #anxiety as a result of diagnosis💡 🔦 More support is required for patients who need it, especially when suicide rates are higher in this population 🔦Novel #biomarkers such as #microRNAs (miRNAs) are additionally under investigation, where they will be useful for patients who have #tumors that may not be able to be easily biopsied Learn more 👉 https://lnkd.in/eGR5jrrS #Oncology #Oncologynews